Contact FedNet to purchase a verbatim transcript
Pharmaceutical Executives on Drug Prices
House Oversight and Reform Committee
Unsustainable Drug Prices: Testimony from the CEOs (Part II)
Thursday October 1, 2020 10:00 a.m.
Room: 2154 Rayburn Bldg.
Mr. Robert Bradway, Chairman and Chief Executive Officer, Amgen Inc.
Mr. Thomas Kendris, U.S. Country President, Novartis AG
Mr. Mark Trudeau, President and Chief Executive Officer, Mallinckrodt Pharmaceuticals